Skip to main content

Advertisement

SpringerLink
Log in

The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch–Schönlein purpura nephritis: A meta-analysis

  • Nephrology-Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Henoch–Schönlein purpura nephritis (HSPN) is the most severe symptom of Henoch–Schönlein purpura. The role of immunosuppressive agents combined with steroids is controversial in treating HSPN. Our meta-analysis was performed to assess the efficacy and safety of the combined therapy in the treatment of HSPN compared with steroids alone.

Methods

Cochrane Library, Pubmed, Embase, and Web of Science were searched and Newcastle–Ottawa Scale was used to assess the quality of the literatures. Odds ratios (OR) and standard mean difference (SMD) with a 95% confidence interval (CI) were used for dichotomous and continuous variables. A random-effect model or fixed-effect analysis was applied according to heterogeneity.

Results

A total of 9 articles were selected in our study. HSPN patients treated with combined therapy demonstrated a significant increase in complete remission rates (OR = 1.95; 95% CI 1.17–3.23, P = 0.010) and total remission rates (OR = 2.30 95% CI 1.33–3.98, P = 0.003) when compared with steroids alone. Children seemed to benefit more from combined treatment (OR = 2.45; CI 1.20–5.02, P = 0.014) than adults (OR = 1.56; CI 0.76–3.20, P = 0.225). Additionally, immunosuppressants plus steroids had an advantage on decreasing proteinuria (SMD = 0.28; CI 0.05–0.52, P = 0.019) and increasing the level of serum albumin (SMD = 0.98; CI 0.35–1.60, P = 0.002). However, significant differences were not found in the estimated glomerular filtration rate (eGFR) and rates of side-effects.

Conclusion

Administration of immunosuppressive agents combined with steroids may be a superior alternative for HSPN. Nevertheless, long-term, high-quality, large-sample, and multicenter RCTs are required to make the results more convincing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Saulsbury FT (2007) Clinical update: Henoch–Schonlein purpura. Lancet 369(9566):976–978. https://doi.org/10.1016/s0140-6736(07)60474-7

    Article  PubMed  Google Scholar 

  2. He X, Yu C, Zhao P, Ding Y, Liang X, Zhao Y, Yue X, Wu Y, Yin W (2013) The genetics of Henoch–Schonlein purpura: a systematic review and meta-analysis. Rheumatol Int 33(6):1387–1395. https://doi.org/10.1007/s00296-012-2661-4

    Article  PubMed  Google Scholar 

  3. Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch–Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Childhood 90(9):916–920. https://doi.org/10.1136/adc.2005.074641

    Article  CAS  Google Scholar 

  4. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch–Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13(5):1271–1278

    Article  PubMed  Google Scholar 

  5. Shrestha S, Sumingan N, Tan J, Alhous H, McWilliam L, Ballardie F (2006) Henoch–Schonlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. J Assoc Phys 99(4):253–265. https://doi.org/10.1093/qjmed/hcl034

    Article  CAS  Google Scholar 

  6. Chapter 11 (2012) Henoch–Schönlein purpura nephritis. Kidney Int Suppl 2(2):218–220. https://doi.org/10.1038/kisup.2012.24

    Article  Google Scholar 

  7. Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch–Schonlein purpura nephritis? Kidney Int 59(3):823–834. https://doi.org/10.1046/j.1523-1755.2001.059003823.x

    Article  CAS  PubMed  Google Scholar 

  8. Oh HJ, Ahn SV, Yoo DE, Kim SJ, Shin DH, Lee MJ, Kim HR, Park JT, Yoo TH, Kang SW, Choi KH, Han SH (2012) Clinical outcomes, when matched at presentation, do not vary between adult-onset Henoch–Schonlein purpura nephritis and IgA nephropathy. Kidney Int 82(12):1304–1312. https://doi.org/10.1038/ki.2012.302

    Article  CAS  PubMed  Google Scholar 

  9. Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions: cochrane book series. https://doi.org/10.1002/9780470712184

  10. Edstrom Halling S, Soderberg MP, Berg UB (2009) Treatment of severe Henoch–Schonlein and immunoglobulin A nephritis. A single center experience. Pediatr Nephrol (Berlin Germany) 24(1):91–97. https://doi.org/10.1007/s00467-008-0990-z

    Article  Google Scholar 

  11. Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch–Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136(3):370–375. https://doi.org/10.1067/mpd.2000.103448

    Article  CAS  PubMed  Google Scholar 

  12. Kawasaki Y, Suzuki J, Suzuki H (2004) Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch–Schoenlein nephritis: a clinical and histopathological study. Nephrology, dialysis, transplantation: official publication of the European dialysis and transplant association. Eur Ren Assoc 19(4):858–864. https://doi.org/10.1093/ndt/gfg617

    Article  CAS  Google Scholar 

  13. Zhang Y, Gao Y, Zhang Z, Liu G, He H, Liu L (2014) Leflunomide in addition to steroids improves proteinuria and renal function in adult Henoch–Schoenlein nephritis with nephrotic proteinuria. Nephrology 19(2):94–100. https://doi.org/10.1111/nep.12175

    Article  CAS  PubMed  Google Scholar 

  14. Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Kim PK, Jeong HJ (2005) Can azathioprine and steroids alter the progression of severe Henoch–Schonlein nephritis in children?. Pediatr Nephrol 20(8):1087–1092. https://doi.org/10.1007/s00467-005-1869-x

    Article  PubMed  Google Scholar 

  15. Devidayal SS, Kumar L, Joshi K, Minz RW, Datta U (2002) Severe Henoch–Schonlein nephritis: resolution with azathioprine and steroids. Rheumatol Int 22(4):133–137. https://doi.org/10.1007/s00296-002-0208-9

    Article  CAS  PubMed  Google Scholar 

  16. Lu Z, Song J, Mao J, Xia Y, Wang C (2017) Evaluation of mycophenolate mofetil and low-dose steroid combined therapy in moderately severe Henoch–Schonlein purpura nephritis. Med Sci Monit 23:2333–2339

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ren P, Han F, Chen L, Xu Y, Wang Y, Chen J (2012) The combination of mycophenolate mofetil with corticosteroids induces remission of Henoch–Schonlein purpura nephritis. Am J Nephrol 36(3):271–277. https://doi.org/10.1159/000341914

    Article  CAS  PubMed  Google Scholar 

  18. Han F, Chen LL, Ren PP, Le JY, Choong PJ, Wang HJ, Xu Y, Chen JH (2015) Mycophenolate mofetil plus prednisone for inducing remission of Henoch–Schonlein purpura nephritis: a retrospective study. J Zhejiang Univ Sci B 16(9):772–779. https://doi.org/10.1631/jzus.B1400335

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Mizerska-Wasiak M, Maldyk J, Demkow U, Roszkowska-Blaim M, Panczyk-Tomaszewska M (2016) Treatment outcomes in children with Henoch–Schonlein nephritis. Adv Exp Med Biol 912:65–72. https://doi.org/10.1007/5584_2016_231

    Article  PubMed  Google Scholar 

  20. Pillebout E, Alberti C, Guillevin L, Ouslimani A, Thervet E (2010) Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch–Schonlein purpura. Kidney Int 78(5):495–502. https://doi.org/10.1038/ki.2010.150

    Article  CAS  PubMed  Google Scholar 

  21. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP (1997) Long-term prognosis of Henoch–Schonlein nephritis in adults and children. Italian group of renal immunopathology collaborative study on Henoch–Schonlein purpura. Nephrology, dialysis, transplantation: official publication of the European dialysis and transplant association. Eur Ren Assoc 12(11):2277–2283

    CAS  Google Scholar 

  22. Guo YN, Wang Z, Lu J (2013) The relationship between children kidney diseases and adult ESRD–an epidemiological investigation of 700 cases. Ren Fail 35(10):1353–1357. https://doi.org/10.3109/0886022x.2013.828262

    Article  PubMed  Google Scholar 

  23. Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez-Gay MA (2002) Henoch–Schonlein purpura in children and adults: clinical differences in a defined population. Sem Arthritis Rheum 32(3):149–156. https://doi.org/10.1053/sarh.2002.33980

    Article  Google Scholar 

  24. Lu S, Liu D, Xiao J, Yuan W, Wang X, Zhang X, Zhang J, Liu Z, Zhao Z (2015) Comparison between adults and children with Henoch–Schonlein purpura nephritis. Pediatr Nephrol 30(5):791–796. https://doi.org/10.1007/s00467-014-3016-z

    Article  PubMed  Google Scholar 

  25. 15th Congress of the International Pediatric Nephrology Association (2010) Pediatr Nephrol 25(9):1779–2004. https://doi.org/10.1007/s00467-010-1577-z

    Article  Google Scholar 

  26. Audemard-Verger A, Terrier B, Dechartres A, Chanal J, Amoura Z, Le Gouellec N, Cacoub P, Jourde-Chiche N, Urbanski G, Augusto JF, Moulis G, Raffray L, Deroux A, Hummel A, Lioger B, Catroux M, Faguer S, Goutte J, Martis N, Maurier F, Riviere E, Sanges S, Baldolli A, Costedoat-Chalumeau N, Roriz M, Puechal X, Andre M, Lavigne C, Bienvenu B, Mekinian A, Zagdoun E, Girard C, Berezne A, Guillevin L, Thervet E, Pillebout E (2017) Characteristics and management of IgA vasculitis (Henoch–Schonlein) in adults: data from 260 patients included in a French multicenter retrospective survey. Arthritis Rheumatol 69 (9):1862–1870. https://doi.org/10.1002/art.40178

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China

    Jiaxing Tan, Yi Tang, Zhengxia Zhong, Li Tan & Wei Qin

  2. West China School of Medicine, Sichuan University, Chengdu, Sichuan, China

    Jiaxing Tan, Zhengxia Zhong, Siyu Yan, Li Tan & Padamata Tarun

Authors
  1. Jiaxing Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yi Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhengxia Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Siyu Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Li Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Padamata Tarun
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wei Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Qin.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest in this manuscript.

Research involving human and animal participants

This article does not contain any studies with human participants performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 92 KB)

Supplementary material 2 (DOCX 16 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, J., Tang, Y., Zhong, Z. et al. The efficacy and safety of immunosuppressive agents plus steroids compared with steroids alone in the treatment of Henoch–Schönlein purpura nephritis: A meta-analysis. Int Urol Nephrol 51, 975–985 (2019). https://doi.org/10.1007/s11255-019-02092-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-019-02092-7

Keywords

Search

Navigation